XML 158 R32.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders’ Equity (Tables) - Titan Pharmaceuticals Inc [Member]
12 Months Ended
Dec. 31, 2024
Subsidiary or Equity Method Investee [Line Items]  
Schedule of Restricted Stock Activity

The following table summarizes restricted stock activity:

 

   2024   2023 
   December 31, 
   2024   2023 
Outstanding at January 1   -    - 
Issued   -    2,500 
Forfeited or expired   -    - 
Released   -    (2,500)
Outstanding at December 31   -    - 
Schedule of Warrants to Purchase Shares of Common Stock

As of December 31, 2024, the following warrants to purchase shares of our common stock were outstanding (in thousands, except per share price):

Date Issued  Expiration Date  Exercise Price   Outstanding 
08/09/2019  02/09/2025  $642.00    5 
01/09/2020  07/09/2025  $150.00    10 
10/30/2020  12/01/2025  $60.00    82 
01/20/2021  07/20/2026  $71.00    102 
02/04/2022  08/04/2027  $22.80    233 
            432 
Schedule of Shares Reserved for Future Issuance

As of December 31, 2024, shares of common stock reserved by us for future issuance consisted of the following (in thousands):

 

      
Stock options outstanding   79 
Shares issuable upon the exercise of warrants   432 
Total   511